Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.

Daniel R MoralesJim SlatteryLuis PinheiroXavier KurzKarin Hedenmalm

Published in: Clinical drug investigation (2018)

Large numbers of fluoroquinolone products in Europe are listed for the treatment of milder infections such as acute bronchitis, acute sinusitis and uUTIs. Among the countries assessed, fluoroquinolones were commonly prescribed for these conditions and potentially should lead to a review of therapeutic guidelines.

Keyphrases

primary care
liver failure
respiratory failure
drug induced
cross sectional
aortic dissection
clinical practice
emergency department
hepatitis b virus
replacement therapy
mechanical ventilation